BioSpace News Archive

BostonGene Corporation, a biomedical software company committed to defining optimal precision medicine-based therapies for cancer patients, today announced a scientific collaboration with Brigham and Women’s Hospital, a world-class academic medical center and a major teaching hospital of Harvard Medical School based in Boston, Massachusetts.

The Lubrizol Corporation has announced that the contract development and manufacturing organization (CDMO) of Lubrizol Life Science Health (LLS Health) has been awarded a grant to support its research on injectable contraceptive formulations designed to bring accessible contraceptive products to women in developing nations.

ProtoKinetix, Incorporated (www.protokinetix.com) (the “Company” or “ProtoKinetix”) (OTCQB: PKTX), a clinical-stage biomedical company, today announced that after the conclusion of 4-years of extensive testing, evidence of fully functional retinal cells was conclusively achieved.

Curevo Vaccine, a clinical stage biopharmaceutical company developing next generation vaccines for patients with infectious disease of global importance, today announced antibody response data from its completed Phase 1 study investigating the safety, tolerability, and immune system response of CRV-101 in several formulations.

Excelra, a global data science and data analytics company, today announced its collaboration with Standigm Inc., a company using artificial intelligence (AI) technology for drug discovery and development.

Intabio, Inc., a developer of analytical solutions that provide profound efficiency gains across all stages of biopharmaceutical development and manufacturing, today released details of several upcoming scientific presentations that highlight the power of Intabio’s microfluidic technology for iCIEF and iCIEF-MS.

Konica Minolta Healthcare Americas, Inc., a recognized leader in medical imaging systems and healthcare IT, announces the latest release of AeroRemote® Insights, a cloud-based, business intelligence and analytics solution that delivers detailed information on asset utilization, department efficiency, imaging system health and more.

Echolight Medical, manufacturer of the innovative EchoS, which can diagnose osteoporosis and assess a person’s risk for the disease within minutes without radiation, is broadening global operations with the opening of its United States headquarters in Seattle.

BIOQUAL’s Board of Directors has declared a dividend of $1.10 per share for shareholders of record on September 28, 2020, payable on October 21, 2020.

Companies nationwide are challenged with ensuring safe and healthy work environments for their people as the pandemic persists.